Q-omics provides the consensus-scored MIR5697 profile across patient tissues and cancer cell-line models. MIR5697 expression is associated with patient survival in 19 of 34 cancer types, with the highest sampling consensus in ACC. Among the 18 cancer types available for tumor–normal comparison, MIR5697 is differentially expressed in 4, with the highest sampling consensus in STAD. Additionally, MIR5697 RNA expression shows 7,020 significant gene co-expression associations, with the highest sampling consensus in ESCA. Together, these results highlight ACC, STAD, and ESCA as cancer lineages where MIR5697 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR5697 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR5697 survival associations across molecular data types. MIR5697 RNA expression shows survival associations in the most cancer types (19). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR5697 RNA expression–survival associations across cancer types. High MIR5697 expression shows unfavorable associations in ACC, MESO, READ, THYM, LGG and KIRP. The ACC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify ACC as the clearest survival context for MIR5697 RNA expression.
This table summarizes MIR5697 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 4. The strongest signals are observed in STAD for RNA.
This table ranks reproducible tumor–normal expression differences for MIR5697. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR5697 shows lower tumor expression in THCA and higher tumor expression in STAD, BRCA and COAD. The STAD box plot shows higher MIR5697 RNA expression in tumor versus normal tissue (log2 FC = +0.505, t-test p = .002).
This table shows molecular features associated with MIR5697 in patient tissues and cancer cell lines. In patient samples, MIR5697 shows the broadest associations at the RNA and protein expression levels, with ESCA recurring as the lineage with the largest associated feature set.
